Position in ALKS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$26,877,217
+$23,735,411 QoQ
Shares Held
512,924
+477.3% QoQ
Ownership
0.306%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#55
of 421 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $106,800,407 across 37 Drug Manufacturers - Specialty & Generic names. ALKS ranks #1 (25.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
This page
|
512,924 | $26,877,217 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
20,421 | $11,064,710 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
51,732 | $8,718,911 | |
| 4 | ZTS |
Zoetis Inc.
|
108,947 | $7,828,931 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
224,462 | $7,782,097 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
68,281 | $7,575,094 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
240,384 | $5,915,850 | |
| 8 | VTRS |
Viatris Inc
|
266,382 | $4,230,146 |
All Filings in ALKS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,877,217 | 512,924 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,141,806 | 88,852 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $14,840,004 | 530,379 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $21,215,880 | 707,196 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $18,786,699 | 656,648 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $18,742,845 | 567,621 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,780,948 | 96,695 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,608,751 | 93,203 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,342,544 | 97,201 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,319,926 | 85,701 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,425,335 | 87,431 | Shares | Defined | 2024-04-22 | |
| 2023-09-30 | $2,448,942 | 87,431 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $2,736,590 | 87,431 | Shares | Defined | 2024-04-29 | |
| 2023-03-31 | $2,404,015 | 85,279 | Shares | Defined | 2024-05-09 | |
| 2022-12-31 | $2,265,862 | 86,715 | Shares | Defined | 2024-05-10 | |
| 2022-09-30 | $1,936,345 | 86,715 | Shares | Defined | 2024-05-10 | |
| 2022-06-30 | $2,518,238 | 84,533 | Shares | Defined | 2024-05-10 | |
| 2022-03-31 | $2,271,868 | 86,350 | Shares | Defined | 2024-05-10 | |
| 2021-12-31 | $1,336,775 | 57,471 | Shares | Defined | 2024-05-17 | |
| 2021-09-30 | $1,772,405 | 57,471 | Shares | Defined | 2024-05-17 | |
| 2021-06-30 | $1,409,188 | 57,471 | Shares | Defined | 2024-05-17 | |
| No filing history on record for this holder in this stock. | ||||||